Elevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells.

TitleElevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells.
Publication TypeJournal Article
Year of Publication2020
AuthorsVega, ME, Finlay, JB, Vasishtha, M, Schwarzbauer, JE
JournalMatrix Biol Plus
Volume8
Pagination100048
Date Published2020 Nov
ISSN2590-0285
Abstract

<p>Mesangial cells are the major extracellular matrix (ECM)-producing cells in the kidney glomerulus and, when exposed to elevated glucose levels, they up-regulate assembly of fibronectin (FN) and other ECM proteins. Increases in glucose concentration are known to alter gene expression; here we investigated the connection between increased ECM production and changes in gene expression in mesangial cells. Comparison of mesangial cells grown in normal or high glucose conditions by RNA-sequencing showed significant expression changes in over 6000 genes and, when grouped by KEGG pathway analysis, identified the ECM-receptor interaction and focal adhesion pathways among the top 5 upregulated pathways. Of note was the significant increase in expression of tenascin-C (TN-C), a known regulator of FN matrix assembly. Mouse TN-C has multiple isoforms due to alternative splicing of 6 FNIII repeat exons. In addition to the transcriptional increase with high glucose, exon inclusion via alternative splicing was also changed resulting in production of higher molecular weight isoforms of TN-C. Mesangial cells grown in normal glucose secreted small isoforms with 1-2 variable repeats included whereas in high glucose large isoforms estimated to include 5 repeats were secreted. Unlike the smaller isoforms, the larger TN-C was not detected in the FN matrix. This change in TN-C isoforms may affect the regulation of FN matrix assembly and in this way may contribute to increased ECM accumulation under high glucose conditions.</p>

DOI10.1016/j.mbplus.2020.100048
Alternate JournalMatrix Biol Plus
PubMed ID33543041
PubMed Central IDPMC7852322
Grant ListF30 DK095515 / DK / NIDDK NIH HHS / United States
R01 AR073236 / AR / NIAMS NIH HHS / United States